Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022
2剂BNT162b2（辉瑞BioNTech）mRNA疫苗预防5-11岁儿童和12-15岁青少年SARS-CoV-2感染的有效性——PROTECT队列研究，2021年7月至2022年2月
期刊:Mmwr-Morbidity and Mortality Weekly Report
影响因子:17.3
doi:10.15585/mmwr.mm7111e1
Fowlkes, Ashley L; Yoon, Sarang K; Lutrick, Karen; Gwynn, Lisa; Burns, Joy; Grant, Lauren; Phillips, Andrew L; Ellingson, Katherine; Ferraris, Maria V; LeClair, Lindsay B; Mathenge, Clare; Yoo, Young M; Thiese, Matthew S; Gerald, Lynn B; Solle, Natasha Schaefer; Jeddy, Zuha; Odame-Bamfo, Leah; Mak, Josephine; Hegmann, Kurt T; Gerald, Joe K; Ochoa, Jezahel S; Berry, Mark; Rose, Spencer; Lamberte, Julie Mayo; Madhivanan, Purnima; Pubillones, Felipe A; Rai, Ramona P; Dunnigan, Kayan; Jones, John T; Krupp, Karl; Edwards, Laura J; Bedrick, Edward J; Sokol, Brian E; Lowe, Ashley; McLeland-Wieser, Hilary; Jovel, Krystal S; Fleary, Deanna E; Khan, Sana M; Poe, Brandon; Hollister, James; Lopez, Joanna; Rivers, Patrick; Beitel, Shawn; Tyner, Harmony L; Naleway, Allison L; Olsho, Lauren E W; Caban-Martinez, Alberto J; Burgess, Jefferey L; Thompson, Mark G; Gaglani, Manjusha
